COR · News · 20260804N
Regulatory Risk
Cencora, Inc. · 2026-08-04 · Importance 51 · Surprise 60 · In source text
The U.S. Federal Trade Commission is scrutinizing Cencora’s proposed $3.5 billion acquisition of Covetrus. The FTC has sent information demands to customers and competitors to evaluate potential effects on veterinary-product availability and practice-management software competition. Cencora announced in February that it planned to sell MWI Animal Health to Covetrus as part of a strategy to divest non-core businesses and focus on pharmaceutical distribution.
Key facts
- The U.S. Federal Trade Commission (FTC) is scrutinizing Cencora's proposed $3.5 billion acquisition of Covetrus. source
- The FTC has sent information demands to customers and rivals of both companies to assess the deal's potential impact on the availability of veterinary products and practice-management software. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| assets | positive | probable | — | The U.S. Federal Trade Commission (FTC) is scrutinizing Cencora's proposed $3.5 billion acquisition of Covetrus. |